Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999164 · ClinicalTrials.gov registry record · Phase 1
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
A Phase 1 study of Epilepsy, Post-Traumatic, sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03999164 is a Phase 1 study of Epilepsy, Post-Traumatic that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03999164, a Phase 1 study of Epilepsy, Post-Traumatic, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to evaluate the time course of inflammation in the brain after a moderate to severe traumatic brain injury using positron emission tomography (PET) brain imaging. Patients will undergo PET scans of the brain at two weeks and two months after injury to measure neuro-inflammation. The results of the PET scans will be analyzed and correlated with the risk of post-traumatic epilepsy.
Conditions Studied
Interventions
- DRUG [18F]DPA-714 Positron Emission Tomography Scan
Study Locations (1)
California
- University of California, Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2026-08-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03999164
The ClinicalTrials.gov registry entry for NCT03999164 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy, Post-Traumatic appearing as the primary indexed condition, and to 1 intervention - of which [18F]DPA-714 Positron Emission Tomography Scan is the first listed.
NCT03999164 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03999164 about?
NCT03999164 is a clinical study titled "Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy". This study plans to evaluate the time course of inflammation in the brain after a moderate to severe traumatic brain injury using positron emission tomography (PET) brain imaging. Patients will undergo PET scans of the brain at two weeks and two months after injury to measure neuro-inflammation. The...
What is the current status of trial NCT03999164?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2020-02-01. Estimated completion is 2026-08-14.
What conditions does trial NCT03999164 study?
This clinical trial studies the following conditions: Epilepsy, Post-Traumatic.
What interventions are being tested in trial NCT03999164?
The interventions under investigation include: [18F]DPA-714 Positron Emission Tomography Scan (DRUG).
Who is sponsoring clinical trial NCT03999164?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03999164 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.